Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Gastrointestinal Cancer
Published in: Journal of Gastrointestinal Cancer 1/2020

01-03-2020 | Carcinoid Tumor | Case Report

Unusual and Aggressive Cause of Gall Bladder Mass—Neuroendocrine Tumor

Authors: Naveen Padmanabhan, Suhail Ahmed, Ann Kurian, P Ravishankar

Published in: Journal of Gastrointestinal Cancer | Issue 1/2020

Login to get access

Excerpt

Neuroendocrine tumor of the gall bladder (GB-NET) is an infrequent entity. GB-NET constitutes 0.2–0.5% of all neuroendocrine tumors and 2% of all gall bladder cancers [1]. There are no specific symptoms or signs for GB-NET and pre-operative differentiation from gall bladder adenocarcinoma is not possible. These tumors are often diagnosed at an advanced stage and have an aggressive behavior [2]. Long-term survivals have been reported in a few patients who are diagnosed at an early stage and successfully treated with multimodality management [3, 4]. In this report, we discuss our patient of GB-NET and our management experience. …
Literature
1.
Mezi S, Petrozza V, Schillaci O, Torre VL, Cimadon B, Leopizzi M, et al. Neuroendocrine tumors of the gallbladder: a case report and review of the literature. J Med Case Rep. 2011;5:334.CrossRef
2.
Kamboj M, Gandhi JS, Gupta G, Sharma A, Pasricha S, Mehta A, et al. Neuroendocrine carcinoma of gall bladder: a series of 19 cases with review of literature. J Gastrointest Cancer. 2015;46(4):356–64.CrossRef
3.
Shimono C, Suwa K, Sato M, Shirai S, Yamada K, Nakamura Y, et al. Large cell neuroendocrine carcinoma of the gallbladder: long survival achieved by multimodal treatment. Int J Clin Oncol. 2009;14(4):351–5.CrossRef
4.
Kim DI, Seo HI, Lee JY, Kim HS, Han KT. Curative resection of combined neuroendocrine carcinoma and adenocarcinoma of the gallbladder. Tumori. 2011;97(6):815–8.CrossRef
5.
Zou Y-P, Li W-M, Liu H-R, Li N. Primary carcinoid tumor of the gallbladder: a case report and brief review of the literature. World J Surg Oncol. 2010;8:12.CrossRef
6.
Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063–72.CrossRef
7.
Duffy A, Capanu M, Abou-Alfa GK, Huitzil D, Jarnagin W, Fong Y, et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol. 2008;98:485–9.CrossRef
8.
Komminoth P, Arnold R, Capella C, Klimstra DS, Kloppel G, Rindi G, et al. Neuroendocrine neoplasms of the gallbladder and extrahepatic bile ducts. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. World health organization of tumours: pathology and genetics of tumours of the digestive system. 4th ed. Lyon (France): International Agency for Research on Cancer (IARC); 2010. p. 274–6.
9.
Travis WD, Linnoila RI, Tsokos MG, Hitchcock CL, Cutler GB Jr, Nieman L, et al. Neuroendocrine tumors of the lung with proposed criteria for large cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical and flow cytometric study of 35 cases. Am J Surg Pathol. 1991;15:529–53.CrossRef
10.
Papotti M, Cassoni P, Sapino A, Passarino G, Krueger JE, AlboresSaavedra J. Large cell neuroendocrine carcinoma of the gallbladder: report of two cases. Am J Surg Pathol. 2000;24:1424–8.CrossRef
11.
Soga J. Primary endocrinomas (carcinoids and variant neoplasms) of the gallbladder. A statistical evaluation of 138 reported cases. J Exp Clin Cancer Res CR. 2003;22(1):5–15.PubMed
12.
Yokoyama Y, Fujioka S, Kato K, Tomono H, Yoshida K, Nimura Y. Primary carcinoid tumor of the gallbladder: resection of a case metastasizing to the liver and analysis of outcomes. Hepatogastroenterology. 2000;47(31):135–9.PubMed
13.
Yun SP, Shin N, Seo HI. Clinical outcomes of small cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder. World J Gastroenterol: WJG. 2015;21(1):269–75.CrossRef
14.
Hirose Y, Sakata J, Endo K, Takahashi M, Saito R, Imano H, et al. A 0.8-cm clear cell neuroendocrine tumor G1 of the gallbladder with lymph node metastasis: a case report. World J Surg Oncol. 2018;16(1):150.CrossRef
15.
Elahi F, Ahmadzadeh A, Yadollahzadeh M, Hassanpour K, Babaei M. Neuroendocrine tumor of the gallbladder. Arch Iran Med. 2013;16:123–5.PubMed
16.
Chen C, Wang L, Liu X, Zhang G, Zhao Y, Geng Z. Gallbladder neuroendocrine carcinoma: report of 10 cases and comparision of clinicopathologic features with gallbladder adenocarcinoma. Int J Clin Exp Pathol. 2015;8(7):8218–26.PubMedPubMedCentral
17.
Okuyama Y, Fukui A, Enoki Y, Morishita H, Yoshida N, Fujimoto S. A large cell neuroendocrine carcinoma of the gall bladder: diagnosis with 18FDG-PET/CT-guided biliary cytology and treatment with combined chemotherapy achieved a long-term stable condition. Jpn J Clin Oncol. 2013;43:571–4.CrossRef
Metadata
Title
Unusual and Aggressive Cause of Gall Bladder Mass—Neuroendocrine Tumor
Authors
Naveen Padmanabhan
Suhail Ahmed
Ann Kurian
P Ravishankar
Publication date
01-03-2020
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 1/2020
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-019-00245-6

Other articles of this Issue 1/2020

Journal of Gastrointestinal Cancer 1/2020 Go to the issue

Original Research

Patterns of Care and Survival Outcomes in the Treatment of Anal Melanoma

Original Research

Influence of Treatment Caused Impairments on Anxiety and Depression in Patients with Cancer of the Esophagus or the Esophagogastric Junction

Original Research

An Examination of Lymph Node Sampling as a Predictor of Survival in Resected Node-Negative Small Bowel Adenocarcinoma: a SEER Database Analysis

Case Report

A Case Report of a Right Mesocolon Solitary Fibrosis Tumour

Original Research

MicroRNA Expression and Correlation with mRNA Levels of Colorectal Cancer-Related Genes

Original Research

Treatment Patterns and Economic Burden by Lines of Therapy Among Patients with Advanced Hepatocellular Carcinoma Treated with Systemic Cancer Therapy
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits